The project Repro-TIL – “Breakthrough Neoantigen-specific Tumor-Infiltrating Lymphocyte Therapies Through Novel Dendritic Cell Reprogramming” – secures a Transition grant from the European Innovation Council (EIC). Coordinated by Asgard Therapeutics, this project joins the expertise of the Pereira Lab and Dr. Inge Marie Svane’s group at Herlev Hospital (Denmark).

The researcher Camille Chatelain from Pereira Lab was awarded a Marie Skłodowska-Curie Actions (MSCA) Postdoctoral Fellowship. MSCA Postdoctoral Fellowships aim to provide researchers with the tools to develop their own projects and advance their careers, while promoting excellence and innovation as prime values. Showcasing a valuable contribution to the field of immunotherapy, Camille Chatelain’s ExpandTILs was one of the selected 1696 projects among 10,360 applications.

Filipe Pereira is joining the SciLifeLab community as one of its Group Leaders – a set of key SciLifeLab members whose contributions to biology and technology promote excellence within the life sciences environment in Sweden and internationally.